CRCM LP position in RNA
ATRIUM THERAPEUTICS INC · Health Care
CRCM LP reported holding 641,539 shares of RNA (ATRIUM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$8.6M, representing 5.68% of its reported portfolio and ranking #3 among its reported holdings. CRCM LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How CRCM LP's RNA position evolved
CRCM LP first disclosed a stake in RNA in Q2 2026 at 641,539 shares (US$8.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 641.54K | $8.63M | New |
About RNA and 13F data
RNA (ATRIUM THERAPEUTICS INC) is a Health Care company. 116 other funds we track also report a position in RNA — the largest reported positions include Sessa Capital IM, L.P. (US$20.2M), TIG Advisors, LLC (US$7.6M), Arbiter Partners Capital Management LLC (US$3.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RNA
- Sessa Capital IM, L.P. 1.50M sh · $20.18M · Q2 2026
- TIG Advisors, LLC 561.53K sh · $7.55M · Q2 2026
- Arbiter Partners Capital Management LLC 261.29K sh · $3.51M · Q2 2026
- Slotnik Capital, LLC 237.64K sh · $3.20M · Q2 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 150.03K sh · $2.02M · Q2 2026
- Bracebridge Capital, LLC 139.24K sh · $1.87M · Q2 2026
- Yakira Capital Management, Inc. 133.05K sh · $1.79M · Q2 2026
- Creek Drive Management Group LLC 127.60K sh · $1.72M · Q2 2026
- Athos Capital Ltd 107.97K sh · $1.45M · Q2 2026
- Marble Bar Asset Management LLP 103.85K sh · $1.40M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 43.76K sh · $588.54K · Q2 2026
- Trium Capital LLP 58.38K sh · $483.40K · Q3 2026
FAQ
How long has CRCM LP held RNA?
CRCM LP has disclosed RNA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is CRCM LP's current position in RNA?
As of Q2 2026, CRCM LP holds 641.54K shares of RNA (ATRIUM THERAPEUTICS INC), valued at $8.63M, representing 5.68% of its reported portfolio and ranking #3.
Has CRCM LP been buying or selling RNA?
In the latest 13F filing (Q2 2026), CRCM LP newly opened its position in RNA.
Which other funds hold RNA?
Other major institutional holders of RNA include Sessa Capital IM, L.P., TIG Advisors, LLC, Arbiter Partners Capital Management LLC, among 116 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.